United States Cell Therapy Markets

 


Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Cell Therapy Markets, Executive SummaryIntroduction to the U.S. Cell Therapy MarketObjectives and PurposeReport Scope and SegmentationReport Structure Patient and Procedural Population StatisticsStatistics on Sites and SpecialistsSummary of Major FindingsTotal Revenue and Revenue Growth RatesPercent of Revenues by Product TypeAnalysis by Major SegmentCompetitive AnalysisUnited States Cell Therapy Markets, Market Engineering Research MethodologyFrost & Sullivan's 12-Step Market Engineering Research MethodologyFrost & Sullivan's 12-Step Market Engineering Research MethodologyFrost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare IndustryFrost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare IndustryResearch SourcesSecondary SourcesPrimary ResearchPharmaceutical Forecast ModelPharmaceutical Forecast ModelPopulation-Based ForecastProduct-Based ForecastMarket Model Assumptions Research Limitations Presentation of Market Engineering Measurements; Definition and their Strategic SignificancePresentation of Market Engineering Measurements; Definition and their Strategic SignificanceGlossary of TermsList of DefinitionsList of AcronymsUnited States Cell Therapy Markets, Challenges in the Cell Therapy MarketIdentification of Challenges Facing the Cell Therapy MarketIdentification of Challenges Facing the Cell Therapy MarketChallengesPatent Piracy Necessitates Indisputable Intellectual Property RightsRegulatory Barriers Delay Product Introduction - Increasing Financial Burden on Cash-Strapped Start-Ups Adaptation of New Technique Slow Due to Need for Advanced Training Uncertainty over Reimbursements Creates Dilemmas for Medical ProfessionControversies over the Use of Embryonal Material Could Hamper Research and Development Use of Cord Blood Raises Serious Ethical and Legal ConcernsEffective Distribution Ensures Continuous Supply of Off-the-Shelf Skin Cell TherapiesLack of Long-Term Vision Threatens Product ApplicationsMarket Engineering Research for the U.S. Organ Cell Therapy Market Market Overview and DefinitionsOverviewDefinitionScope/SegmentationProduct LinesProduct ClassificationTransplant ProceduresUnit DefinitionMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversSevere Shortage of Donor Organs for Transplant Creates Pull EffectMajor Universities and Manufacturers Form Associations and Teams to Pool Resources for Viable ProductsHigh Degree of Graft Rejection Creates Problems for Allograft Patients Current Transplant Techniques Prove Prohibitively Expensive Human Cell Testing Receives Concentrated Focus as FDA Rescinds Approval for Porcine Cell Testing Xenograft Organ Transplants Raise Ethical Issues and Distaste Among Patients Synthetic Organs Do Not Replicate All Functions of Human OrgansPharmaceutical Companies Fund Research Through PartnershipsHepatitis B and C Epidemics Expected to Increase Incidence of Liver CirrhosisDisparity of Costs Presents High Potential for Savings - Winning Support from Third-Party PayersMarket RestraintsMarket RestraintsLong Periods of Clinical Trials Required Before FDA Approval Is Given to Market Products Funding and Financial Constraints Threaten Survival of Companies Achieving Vascularization in Engineered Organs Still Problematic High Rate of Attrition and Mobility of Key Research Scientists Hinders Product DevelopmentCarcinogenic Possibilities Limit Internal Tissue RegenerationProposed Inclusions of Suboptimal Donors May Expand Pool of Available Organs for TransplantLimited Length of Islet and Organ Viability Require Multiple TransplantsFear of Litigation from Failed Procedures Impedes Physician AcceptanceMarket Engineering Unit and Revenue Forecasts (1995-2005)Potential RevenuesMarket Engineering Unit and Revenue Forecasts for Extracorporeal Liver Assist Devices (1995-2005)Competitive Analysis of the Total Bioartificial Organs MarketCompetitive StructureCompetitive FactorsMergers; Acquisitions Alliances and Research PartnershipsMarket LeadersProduct AnalysisProduct AnalysisProducts in DevelopmentMarket Engineering Research for the Cartilage Cell Therapy MarketMarket Overview and DefinitionsOverviewDefinitionScope/SegmentationHistoryApplications/UseAccessories/Unit DefinitionAccessories/Unit DefinitionMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversCartilage Replacement Helps to Slow or Prevent ArthritisCartilage Replacement Provides an Attractive Alternative to Current Minimal Treatment OptionArthroscopic Surgery Not Always Successful in Treating Knee InjuriesReduction in Treatment Costs Drives ProceduresReduction in Treatment Costs Drives ProceduresIntrinsic Properties of Chondrocytes Make Them Ideal Cell Therapy ProductsMarket RestraintsMarket RestraintsCartilage Replacement Procedure Is LengthyLimited Experience with Cartilage Replacement Techniques Mandates More Studies and Training Cartilage Replacement Is Not a Favorable Option for All ConditionsResistance from Insurance Companies Might Discourage Frequency of ProceduresMarket Engineering and Revenue Forecasts (1995-2005)Unit and Revenue Forecasts Technology TrendsCompetitive AnalysisCompetitive StructureCompetitive FactorsMergers; Alliances and AcquisitionsMarket Share AnalysisMarket Share Winners and WhyProduct AnalysisProducts on the MarketProducts in Development/Clinical TrialsMarket Engineering Research for the U.S. Skin Cell Therapy MarketTotal Market AnalysisOverviewDefinitionScope/SegmentationDevice ClassificationApplications/UsePatients/ProceduresAccessories/Unit DefinitionMarket DriversMarket RestraintsMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1995-2005)Total RevenuesRevenue Trends by Product TypeCompetitive AnalysisMarket Engineering Analysis of the U.S. Acute Wound Cell Therapy MarketMarket Overview and DefinitionsMarket Engineering Unit and Revenue Forecasts (1995-2005)Competitive AnalysisMarket Engineering Analysis of the U.S. Chronic Wound Cell Therapy MarketMarket Overview and DefinitionsMarket Engineering Unit and Revenue Forecasts (1995-2005)Competitive AnalysisMarket Engineering Research for the Neurodegenerative Diseases Cell Therapy Market Market Overview and DefinitionsOverviewDefinitionScope/SegmentationHistoryApplications/UseDisease OverviewMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversImplants Containing Engineered Neuronal Cells Help in Avoiding Blood Brain BarrierStem Cell Research Presents an Alternative Treatment Option for Neuronal Damage Increase in Aging Population Driving the Push for Neuronal Stem Cell TherapiesImproved Regulatory Review Process Driving Research Market RestraintsMarket RestraintsSource of Material of the Neural Cell Therapies Is a Serious ConcernMore Clinical Studies Needed to Prove EfficacyConcerns over Failure of ImplantsMarket Engineering Unit and Revenue Forecasts (1995-2005)Patients/ProceduresTechnology TrendsNeurotrophic Factors Used in the Treatment of Neurodegenerative DiseasesSmall-Molecule Drugs Overcome the Blood Brain Barrier for DeliveryGene Therapy As a Means of Presenting Long-Term Correction of DiseaseCompetitive AnalysisCompetitive StructureCompetitive FactorsMergers; Alliances and AcquisitionsProduct AnalysisProducts in Clinical Trials and DevelopmentMarket Engineering Research for the Stem Cell Therapy MarketTotal Market AnalysisMarket Overview and DefinitionsMarket DriversMarket RestraintsMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1997-2005)Competitive AnalysisTechnology TrendsCompeting TechnologiesMarket Share AnalysisProduct Analysis




Related Research

Release Date : 11-Aug-17

Region : North America

Release Date : 10-Aug-17

Region : North America

Release Date : 09-Aug-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.